Topic: Internal Medicine
Diabetics who seek to aggressively lower their blood pressure and cholesterol are not reducing their risk of a heart attack and could suffer negative side effects, a study released Sunday said. The results of the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial appear to repudiate years of medical advice for type-2 diabetics who face a high ...
Key results from a landmark federal study are in, and the results are disappointing for diabetics: Adding drugs to drive blood pressure and blood-fats lower than current targets did not prevent heart problems, and in some cases caused harmful side effects. A decade ago, the federal ...
Farmed Salmon: I am sure you have heard about Omega-3 fatty acids and how we get too few in our diet. Omega-3's are essential for heart health and for emotional and mental well-being. You may not be aware, however, that farmed salmon contains a lot fewer Omega-3 fatty acids compared to wild salmon. In addition, farmed salmon is much ...
ATLANTA (Reuters) - The Novartis diabetes drug Starlix failed to reduce progression to the disease or cut down on serious heart problems in patients at high risk for both diabetes and heart disease, according to a large study released on Sunday. The 9,306-patient study tested Starlix, known chemically as nateglinide, and the big-selling Novartis blood pressure medicine Diovan. Diovan, known ...
